First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
University of Southern California, Norris Comprehensive Cancer Center 90033 Los Angeles United StatesRekrutierend» Google-MapsChristiana Care Health Services 19713 Newark United StatesRekrutierend» Google-MapsHenry Ford Health System 48202 Detroit United StatesRekrutierend» Google-MapsRutgers Cancer Institute of New Jersey 08901 New Brunswick United StatesRekrutierend» Google-MapsNew York University Langone Medical Center 10016 New York United StatesRekrutierend» Google-MapsThe University of North Carolina at Chapel Hill 27599 Chapel Hill United StatesRekrutierend» Google-MapsAvera Cancer Institute 57105 Sioux Falls United StatesRekrutierend» Google-MapsSwedish Cancer Institute Medical Oncology 98104 Seattle United StatesRekrutierend» Google-MapsWest Virginia University Health Sciences Center 26506 Morgantown United StatesRekrutierend» Google-MapsChris OBrien Lifehouse 2050 Camperdown AustraliaRekrutierend» Google-MapsUniversitair Ziekenhuis Antwerpen 2650 Edegem BelgiumRekrutierend» Google-MapsAlgemeen Ziekenhuis Maria Middelares 9000 Gent BelgiumRekrutierend» Google-MapsJessa Ziekenhuis - Campus Virga Jesse 3500 Hasselt BelgiumRekrutierend» Google-MapsAZ Delta Campus Rumbeke 8800 Roeselare BelgiumRekrutierend» Google-MapsPrincess Margaret Cancer Centre M5G 2M9 Toronto CanadaRekrutierend» Google-MapsCHU de Quebec Hopital de l Enfant Jesus G1R 2J6 Quebec CanadaRekrutierend» Google-MapsRigshospitalet 2100 Kobenhavn DenmarkAbgebrochen» Google-MapsCentre Leon Berard 69373 Lyon cedex 8 FranceRekrutierend» Google-MapsCentre Hospitalier Universitaire de Nantes, Hôpital Nord Laënnec 44800 Saint Herblain FranceRekrutierend» Google-MapsGustave Roussy 94805 Villejuif FranceRekrutierend» Google-MapsRambam Medical Center 3109601 Haifa IsraelRekrutierend» Google-MapsHadassah Ein-Kerem Medical Center 9112001 Jerusalem IsraelRekrutierend» Google-MapsRabin Medical Center 4941492 Petah Tikva IsraelRekrutierend» Google-MapsSheba Medical Center 5265601 Ramat Gan IsraelRekrutierend» Google-MapsAzienda Ospedaliera Universitaria Renato Dulbecco 88100 Catanzaro ItalyRekrutierend» Google-MapsFondazione IRCCS San Gerardo dei Tintori 20900 Monza (MB) ItalyRekrutierend» Google-MapsIstituto Nazionale Tumori Regina Elena 00144 Rome ItalyRekrutierend» Google-MapsNational Cancer Center Hospital East 277-8577 Kashiwa-shi JapanRekrutierend» Google-MapsThe Cancer Institute Hospital of Japanese Foundation for Cancer Research 135-8550 Koto-ku JapanRekrutierend» Google-MapsSeoul National University Hospital 03080 Seoul Korea, Republic ofRekrutierend» Google-MapsAsan Medical Center 05505 Seoul Korea, Republic ofRekrutierend» Google-MapsSamsung Medical Center 06351 Seoul Korea, Republic ofRekrutierend» Google-MapsUniversitair Medisch Centrum Groningen 9713 GZ Groningen NetherlandsRekrutierend» Google-MapsInstitut Catala d Oncologia Badalona Hospital Universitari Germans Trias i Pujol 08916 Badalona SpainRekrutierend» Google-MapsHospital Universitari Vall d Hebron 08035 Barcelona SpainRekrutierend» Google-MapsHospital Universitario 12 de Octubre 28041 Madrid SpainRekrutierend» Google-MapsUniversitaetsspital Basel 4031 Basel SwitzerlandRekrutierend» Google-MapsInselspital Bern 3010 Bern SwitzerlandRekrutierend» Google-MapsNational Cheng Kung University Hospital 70403 Tainan TaiwanRekrutierend» Google-MapsNational Taiwan University Hospital 10002 Taipei TaiwanRekrutierend» Google-MapsTaipei Veterans General Hospital 11217 Taipei TaiwanRekrutierend» Google-Maps
Tarlatamab (AMG 757): Tarlatamab will be administered as an intravenous (IV) infusion.
Carboplatin: Carboplatin will be administered as an intravenous (IV) infusion.
Etoposide: Etoposide will be administered as an intravenous (IV) infusion.
Atezolizumab (Tecentriq): Atezolizumab will be administered as an intravenous (IV) infusion.
Durvalumab: Durvalumab will be administered as an intravenous (IV) infusion.
Quelle: ClinicalTrials.gov
Sie können folgenden Inhalt einem Kollegen empfehlen:
"First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)"
Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.
Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!